| Dr Sukhjinder Singh Brah, MD | |
|
1220 Rossmoor Pkwy, Walnut Creek, CA 94595-2501 | |
| (925) 947-3393 | |
| (925) 947-3396 |
| Full Name | Dr Sukhjinder Singh Brah |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 1220 Rossmoor Pkwy, Walnut Creek, California |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023044559 | NPI | - | NPPES |
| 00A916870 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A91607 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John Muir Physician Network | 6608789813 | 464 |
News Archive
Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of Dynamic Bone, a unique expandable allograft bone provided by Dynamic Surgical Solutions and BioDfence DryFlex, an easy to handle, flexible amniotic membrane manufactured by BioDlogics.
These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
George Mason University Professor Dr. Kenneth W. Griffin, received $156,581 from National Health Promotion Associates for a project aimed at preventing prescription drug use among high school students.
› Verified 1 days ago
| Entity Name | John Muir Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841407665 PECOS PAC ID: 6608789813 Enrollment ID: O20031226000143 |
News Archive
Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of Dynamic Bone, a unique expandable allograft bone provided by Dynamic Surgical Solutions and BioDfence DryFlex, an easy to handle, flexible amniotic membrane manufactured by BioDlogics.
These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
George Mason University Professor Dr. Kenneth W. Griffin, received $156,581 from National Health Promotion Associates for a project aimed at preventing prescription drug use among high school students.
› Verified 1 days ago
| Entity Name | John Muir Trauma Physicians Billing Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093864837 PECOS PAC ID: 3476542515 Enrollment ID: O20050420001452 |
News Archive
Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of Dynamic Bone, a unique expandable allograft bone provided by Dynamic Surgical Solutions and BioDfence DryFlex, an easy to handle, flexible amniotic membrane manufactured by BioDlogics.
These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
George Mason University Professor Dr. Kenneth W. Griffin, received $156,581 from National Health Promotion Associates for a project aimed at preventing prescription drug use among high school students.
› Verified 1 days ago
| Entity Name | Sukhjinder S Brah Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326811928 PECOS PAC ID: 2961848346 Enrollment ID: O20240307001926 |
News Archive
Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of Dynamic Bone, a unique expandable allograft bone provided by Dynamic Surgical Solutions and BioDfence DryFlex, an easy to handle, flexible amniotic membrane manufactured by BioDlogics.
These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
George Mason University Professor Dr. Kenneth W. Griffin, received $156,581 from National Health Promotion Associates for a project aimed at preventing prescription drug use among high school students.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sukhjinder Singh Brah, MD Dept 34929, P.o. Box 39000, San Francisco, CA 94139-0001 Ph: (925) 952-2828 | Dr Sukhjinder Singh Brah, MD 1220 Rossmoor Pkwy, Walnut Creek, CA 94595-2501 Ph: (925) 947-3393 |
News Archive
Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of Dynamic Bone, a unique expandable allograft bone provided by Dynamic Surgical Solutions and BioDfence DryFlex, an easy to handle, flexible amniotic membrane manufactured by BioDlogics.
These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
George Mason University Professor Dr. Kenneth W. Griffin, received $156,581 from National Health Promotion Associates for a project aimed at preventing prescription drug use among high school students.
› Verified 1 days ago
Dr. Joseph Patrick Henry, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396 | |
Mr. Ramin Khashayar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1399 Ygnacio Valley Rd, Ste 14, Walnut Creek, CA 94598 Phone: 925-939-3050 Fax: 925-939-3057 | |
Dr. Hennessey Tseng, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd, Suite 220b, Walnut Creek, CA 94597 Phone: 925-937-1770 Fax: 925-937-0630 | |
Dr. Ali-reza Barmaki, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396 | |
Dr. Cynthia M. Mullen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-322-2372 Fax: 925-322-6720 | |
Mr. David Nathanson, Internal Medicine Medicare: Medicare Enrolled Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000 | |
Mark D Nathan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 La Casa Via, #140, Walnut Creek, CA 94598 Phone: 925-274-2860 Fax: 925-932-4527 |